ARS Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
ARS Wealth Advisors's AMGN Position: Q2 2021 in Review
ARS Wealth Advisors increased its Amgen (AMGN) stake by 1.2% in Q2 2021, buying an estimated $7.38K and bringing the position to 2,437 shares worth $594K. The position accounts for 0.11% of the portfolio, ranked #78.
ARS Wealth Advisors first reported a position in AMGN in Q3 2018 and has held it in 11 quarters since. The position peaked at $599K in Q1 2021. 2,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.
- ARS Wealth Advisors held 2,437 shares of Amgen worth $594K as of Q2 2021.
- ARS Wealth Advisors bought 30 Amgen shares in Q2 2021, an estimated $7.38K.
- Amgen made up 0.11% of ARS Wealth Advisors's portfolio in Q2 2021, its #78 holding.
- ARS Wealth Advisors first reported a position in Amgen in Q3 2018 and has held it in 11 quarters since.
- ARS Wealth Advisors's Amgen position peaked at $599K in Q1 2021.
- 2,195 funds tracked by Wall St. Rank held Amgen as of Q2 2021.
Based on ARS Wealth Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.